Hasil Pencarian - Fatemeh Rahbarizadeh

Perbaiki Hasil
  1. 1
    T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts

    T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts oleh Fatemeh Nasiri, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh, Fatemeh Rahbarizadeh

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Phospholipase-Cγ1 Signaling Protein Down-Regulation By Oligoclonal-VHHs Based Immuno-Liposome: A Potent Metastasis Deterrent In HER2 Positive Breast Cancer Cells

    Phospholipase-Cγ1 Signaling Protein Down-Regulation By Oligoclonal-VHHs Based Immuno-Liposome: A Potent Metastasis Deterrent In HER2 Positive Breast Cancer Cells oleh Ommolbanin Asadpour, Fatemeh Rahbarizadeh

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    CAR-T cell potency: from structural elements to vector backbone components

    CAR-T cell potency: from structural elements to vector backbone components oleh Marzieh Mazinani, Fatemeh Rahbarizadeh

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Polyethyleneimine-polyethylene glycol copolymer targeted by anti-HER2 nanobody for specific delivery of transcriptionally targeted tBid containing construct

    Polyethyleneimine-polyethylene glycol copolymer targeted by anti-HER2 nanobody for specific delivery of transcriptionally targeted tBid containing construct oleh Batoul Saqafi, Fatemeh Rahbarizadeh

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    PE38-based gene therapy of HER2-positive breast cancer stem cells via VHH-redirected polyamidoamine dendrimers

    PE38-based gene therapy of HER2-positive breast cancer stem cells via VHH-redirected polyamidoamine dendrimers oleh Cobra Moradian, Fatemeh Rahbarizadeh

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    New cell sources for CAR-based immunotherapy

    New cell sources for CAR-based immunotherapy oleh Marzieh Mazinani, Fatemeh Rahbarizadeh

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward

    Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward oleh Pouya Safarzadeh Kozani, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh, Fatemeh Rahbarizadeh

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Strategies for Dodging the Obstacles in CAR T Cell Therapy

    Strategies for Dodging the Obstacles in CAR T Cell Therapy oleh Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh, Fatemeh Rahbarizadeh, Shahryar Khoshtinat Nikkhoi

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display

    Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display oleh Mahmoud Ganji, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Effect of Anti-CD3/CD28 Dynabeads and Allogeneic PBMCs on Expansion of Anti-MUC1 Chimeric Receptor T Cells

    Effect of Anti-CD3/CD28 Dynabeads and Allogeneic PBMCs on Expansion of Anti-MUC1 Chimeric Receptor T Cells oleh Alireza Rajabzadeh, Fatemeh Rahbarizadeh, Amir Ali Hamidieh

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells

    Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells oleh Alireza Rajabzadeh, Amir Ali Hamidieh, Fatemeh Rahbarizadeh

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

    Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero? oleh Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Milad Ahmadi Najafabadi, Fatemeh Yousefi, Seyed Mohamad Javad Mirarefin, Fatemeh Rahbarizadeh, Fatemeh Rahbarizadeh

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells

    CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells oleh Elahe Kamali, Fatemeh Rahbarizadeh, Zohreh Hojati, Morten Frödin

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries

    Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries oleh Saeedeh Ghiasvand, Fatemeh Rahbarizadeh, Babak Bakhshinejad, Majid Sadeghizadeh

    Diterbitkan 2015-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Novel antigens of CAR T cell therapy: New roads; old destination

    Novel antigens of CAR T cell therapy: New roads; old destination oleh Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Humanization of the antigen-recognition domain does not impinge on the antigen-binding, cytokine secretion, and antitumor reactivity of humanized nanobody-based CD19-redirected CAR-T cells

    Humanization of the antigen-recognition domain does not impinge on the antigen-binding, cytokine secretion, and antitumor reactivity of humanized nanobody-based CD19-redirected CAR... oleh Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

    CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit? oleh Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries

    Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries oleh Saeedeh Ghiasvand, Fatemeh Rahbarizadeh, Babak Bakhshinejad, Majid Sadeghizadeh

    Diterbitkan 2015-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    A comprehensive comparison between camelid nanobodies and single chain variable fragments

    A comprehensive comparison between camelid nanobodies and single chain variable fragments oleh Yasaman Asaadi, Fatemeh Fazlollahi Jouneghani, Sara Janani, Fatemeh Rahbarizadeh

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy

    Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy oleh Seyed Moein Moghimi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: